MFN2 and Alzheimer disease: In particular, increased expression of DRP1 and FIS1 and decreased expression of Mfn1, Mfn2, Opa1 and Tomm40 were reported in APP transgenic mice primary hippocampal neurons and in AD brains [126,127].